Clinical trial Recruiting at 1 site Observational Ages 18 and up Women only

Epidural hydroxyethyl starch to prevent post-dural puncture headache in parturients

Official title: Effect of Epidural Hydroxyethyl Starch Administration for Prevention of Post-Dural Puncture Headache in Parturients: A Multi-center Prospective Cohort Study

Run by Peking University First Hospital · NCT07914790 · Data updated 2026-11-12

This study tests whether filling the epidural space with hydroxyethyl starch can help prevent post-dural puncture headaches in women who had an accidental dural puncture during epidural anesthesia for labor or cesarean delivery.

Quick facts

Study typeObservational
Ages18 Years and up
SexWomen only
Enrollment410 (estimated)
SponsorPeking University First Hospital
Academic / other
Locations4 sites (Beijing, Beijing Municipality and 3 other locations)
StatusRecruiting
StartedNovember 4, 2026
Main results expectedDecember 2029
Study endsJune 2030
Registry record updatedNovember 6, 2026
Trial IDNCT07914790 on ClinicalTrials.gov

Is this trial a fit for you?

Likely a good fit

Adult parturients (age ≥18) who experience accidental dural puncture during epidural labor analgesia or neuraxial anesthesia for cesarean delivery.

Probably not a fit

Patients without ADP or those not receiving epidural catheter-based interventions may not benefit from this approach.

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This multicenter prospective cohort project investigates the effect of epidural hydroxyethyl starch (HES) filling on preventing PDPH after accidental dural puncture in parturients. Participants are women aged 18 or older who experienced ADP during neuraxial anesthesia for labor analgesia or cesarean delivery. The study compares outcomes between those receiving TEG/epidural HES filling and those who do not, across several Chinese hospitals. Background data describe the incidence of ADP and PDPH, current conservative and pharmacologic treatments, and the rationale for using epidural HES to reduce CSF leakage. The study design is observational, focusing on real-world practice across multiple centers to assess feasibility and potential benefit. Primary endpoints likely include incidence and severity of PDPH, with secondary outcomes on analgesic requirements and recovery metrics.

Why it matters

Potential benefit: If successful, epidural HES filling could reduce the risk or severity of PDPH in parturients who experience ADP, potentially improving comfort and recovery.

How similar studies have gone: Previous reports describe the use of epidural filling with HES to prevent PDPH, but robust prospective data in parturients are limited, making this evaluation relatively novel.

Who can join: the full rules

Show full inclusion / exclusion criteria
Inclusion Criteria:

1. Age ≥18 years.
2. Have experienced accidental dural puncture (ADP) during epidural labor analgesia or neuraxial anesthesia for cesarean delivery.

Exclusion Criteria:

1. Age \<18 years.
2. ASA physical status ≥IV.
3. Cesarean delivery under general anesthesia.
4. Preoperative inability to communicate due to intellectual or language impairment.
5. Pre-existing cerebrovascular disease, migraine, or chronic headache.
6. Long-term use of oral analgesics.
7. Preoperative coagulation dysfunction.
8. Platelet count \<80×10⁹/L.
9. Refusal to participate.

Where it's running

  • Peking University First Hospital
    Beijing, Beijing Municipality, China
    Recruiting
  • Beijing Haidian Maternal and Child Health Hospital
    Beijing, Beijing Municipality, China
    Not yet recruiting
  • Ningxia Maternal and Child Health Hospital
    Yinchuan, Ningxia, China
    Not yet recruiting
  • Taiyuan central hospital
    Taiyuan, Shanxi, China
    Not yet recruiting

Study contacts

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

How to take part

  1. Review the eligibility criteria above with your treating physician.
  2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
  3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.